The UAE's Ministry of Health (MoH) has licensed the world's first oral medication for Multiple Sclerosis (MS) ensuring that the country's 1,000 MS sufferers have fast access to the latest medications that will change the treatment of MS, it was announced at a press conference today.
The MoH has approved the Novartis-made drug GilenyaTM (fingolimod) for use in the relapsing remitting form of MS that affects around two-thirds of those diagnosed with the disease, which causes muscle weakness, problems with coordination and impaired concentration...........
Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309